Clicky

Cellectis Romainvil(CMVLF) News

Date Title
Jul 25 European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Gain 1.6% for Week
Jul 24 European Penny Stocks Worth Watching In July 2025
Jul 23 European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
Jul 22 European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Jul 18 European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
Dec 29 Analysts Predict 400% Upside Potential for This Penny Stock
Aug 26 Cellectis Publishes a Molecular Therapy Article on a SMART DUAL CAR T-cell Approach for Treating Recalcitrant Solid Tumors
Jul 25 FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis’ UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment
Jun 18 Cellectis (CLLS) Upgraded to Buy: Here's Why
Jun 18 After Plunging -27.95% in 4 Weeks, Here's Why the Trend Might Reverse for Cellectis (CLLS)
Jun 12 Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications
May 7 AstraZeneca concludes equity investment in Cellectis
May 6 AstraZeneca ups stake in Cellectis in latest cell therapy bet
May 6 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
Apr 22 Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
Jan 16 Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)
Dec 22 Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023
Dec 1 Monthly information on share capital and company voting rights
Jun 28 Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 27, 2023
Apr 27 Cellectis to Report First Quarter 2023 Financial Results on May 4, 2023